Surviving Sepsis Campaign

Revision as of 17:11, 25 January 2009 by LBiller (talk | contribs) (New page: {{SI}} {{EH}} ==Overview== The '''Surviving Sepsis Campaign''' (SSC) is a global initiative to bring together professional organizations in reducing mortality from sepsis. The purpos...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Surviving Sepsis Campaign

Articles

Most recent articles on Surviving Sepsis Campaign

Most cited articles on Surviving Sepsis Campaign

Review articles on Surviving Sepsis Campaign

Articles on Surviving Sepsis Campaign in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Surviving Sepsis Campaign

Images of Surviving Sepsis Campaign

Photos of Surviving Sepsis Campaign

Podcasts & MP3s on Surviving Sepsis Campaign

Videos on Surviving Sepsis Campaign

Evidence Based Medicine

Cochrane Collaboration on Surviving Sepsis Campaign

Bandolier on Surviving Sepsis Campaign

TRIP on Surviving Sepsis Campaign

Clinical Trials

Ongoing Trials on Surviving Sepsis Campaign at Clinical Trials.gov

Trial results on Surviving Sepsis Campaign

Clinical Trials on Surviving Sepsis Campaign at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Surviving Sepsis Campaign

NICE Guidance on Surviving Sepsis Campaign

NHS PRODIGY Guidance

FDA on Surviving Sepsis Campaign

CDC on Surviving Sepsis Campaign

Books

Books on Surviving Sepsis Campaign

News

Surviving Sepsis Campaign in the news

Be alerted to news on Surviving Sepsis Campaign

News trends on Surviving Sepsis Campaign

Commentary

Blogs on Surviving Sepsis Campaign

Definitions

Definitions of Surviving Sepsis Campaign

Patient Resources / Community

Patient resources on Surviving Sepsis Campaign

Discussion groups on Surviving Sepsis Campaign

Patient Handouts on Surviving Sepsis Campaign

Directions to Hospitals Treating Surviving Sepsis Campaign

Risk calculators and risk factors for Surviving Sepsis Campaign

Healthcare Provider Resources

Symptoms of Surviving Sepsis Campaign

Causes & Risk Factors for Surviving Sepsis Campaign

Diagnostic studies for Surviving Sepsis Campaign

Treatment of Surviving Sepsis Campaign

Continuing Medical Education (CME)

CME Programs on Surviving Sepsis Campaign

International

Surviving Sepsis Campaign en Espanol

Surviving Sepsis Campaign en Francais

Business

Surviving Sepsis Campaign in the Marketplace

Patents on Surviving Sepsis Campaign

Experimental / Informatics

List of terms related to Surviving Sepsis Campaign

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

The Surviving Sepsis Campaign (SSC) is a global initiative to bring together professional organizations in reducing mortality from sepsis.

The purpose of the SSC is to create an international collaborative effort to improve the treatment of sepsis and reduce the high mortality rate associated with the condition.

This is done using a six pronged approach:

  • Building awareness of sepsis
  • Improving diagnosis
  • Increasing the use of appropriate treatment
  • Educating healthcare professionals
  • Improving post-ICU care
  • Developing guidelines of care
  • Facilitating data collection for the purposes of audit and feedback (SSC Guidelines 2008)

The Surviving Sepsis Campaign and the Institute for Healthcare Improvement have teamed up to achieve a 25 percent reduction in sepsis mortality by 2009.

Relevance

Mortality associated with severe sepsis remains high at 30-50%. When shock is present, mortality is reported to be even higher at around 50-60%. Approximately 1400 people die from sepsis each day throughout the world.

In the U.S. there are approximately 750,000 new sepsis cases each year, with at least 210,000 fatalities and this is reported to be same throughout Europe. As medicine becomes more advanced, with invasive procedures and immunosuppression, the incidence of sepsis is likely to increase even more.

Using Bundles in Health Care

This simplifies the complex processes of the care of patients with severe sepsis. A bundle is a selected set of elements of care distilled from evidence-based practice guidelines that, when implemented as a group, have an effect on outcomes beyond implementing the individual elements alone. Each hospital's sepsis protocol may be customized, but it must meet the standards created by the bundle.

The first 6 hour SSC Resuscitation Bundle includes:

  • Blood cultures obtained prior to antibiotic administration.
  • serum lactate measured
  • Broad-spectrum antibiotics administered within two hours of admission/diagnosis. For every hour a patient is denied AB therapy after the onset of septic shock, the patients chance of survival is reduced by 7.9% (Survivesepsis.org 2005)

Further management is centered around Early Goal Directed Therapy (EGDT).

  • In the event of hypotension and/or lactate > 4 mmol/L, delivering an initial minimum of 20 ml/kg of crystalloid or 5mls/kg of colloid
  • Apply vasopressors, usually noradrenaline for hypotension not responding to initial fluid resuscitation to maintain mean arterial pressure (MAP) > 65 mm Hg, in the event of persistent hypotension despite fluid resuscitation (septic shock) and/or lactate > 4 mmol/L (36 mg/dl):

Resuscitation Goals are:

  • To achieve central venous pressure (CVP) of > 8 mm Hg
  • To achieve central venous oxygen saturation (ScvO2) of > 70%
  • To achieve MAP > 65mmHg and a urine output of >0.5mls/kg/hr

The 24 hour SSC Management Bundle includes:

  • Low-dose steroids administered for septic shock in accordance with a standardized ICU policy
  • activated protein C administered in certain conditions
  • Glucose control maintained below upper limit of normal (8.3 mmol/L) with an insulin sliding scale regime (usually short-acting insulin such as Human Actrapid)
  • Lung Protective Ventilator Strategy utilising 5-8 mls/kg tidal volumes for mechanically ventilated patients to avoid volutrauma and barotrauma.

References

  • Dellinger RP, Levy MM, Carlet JM, et.al. International Surviving Sepsis Campaign Guidelines Committee. "Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2008." Crit Care Med. 2008;36(1):296-327. PMID 18158437

External links

Template:SIB Template:WH Template:WS